Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision changed from v3.6.2 to v3.6.3, indicating a subsequent update to the study record. This update appears to be a metadata/version change rather than a substantive alteration to the study content.SummaryDifference0.0%

- Check22 days agoChange DetectedThe page now shows Revision: v3.6.2, indicating a newer version of the study details page. This reflects a version-control update rather than a change to the trial information.SummaryDifference0.0%

- Check36 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is no longer enrolling. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Interception/Treatment label formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

- Check43 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new deployment; the change is limited to metadata without visible content alterations.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page revision. This appears to be a metadata update rather than a change to core content or user-facing features.SummaryDifference0.0%

- Check79 days agoChange DetectedA new citation to the 2026 JAMA Dermatology article by Yosipovitch et al. was added; the prior 2025 online-ahead-of-print citation in Dermatol Ther (Heidelb) was removed.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.